Your browser doesn't support javascript.
loading
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
Lynch, Joseph P; Fishbein, Michael C; Abtin, Fereidoun; Zhanel, George G.
Affiliation
  • Lynch JP; Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, Department of Internal Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Fishbein MC; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Abtin F; Section of Radiology Cardiothoracic and Interventional, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Zhanel GG; Department of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
Expert Rev Anti Infect Ther ; 21(7): 723-736, 2023.
Article in En | MEDLINE | ID: mdl-37262298

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Diabetes Mellitus / Mucorales / Mucormycosis Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Expert Rev Anti Infect Ther Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Diabetes Mellitus / Mucorales / Mucormycosis Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Expert Rev Anti Infect Ther Year: 2023 Document type: Article